E. A. Morales

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma

M. Sadelain, E. Vertes, A. Bograd, 2011, Cancer Immunology, Immunotherapy.

Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Prasad S Adusumilli, C. Sima, V. Rusch, 2013, Journal of the National Cancer Institute.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

D. Centonze, G. Marfia, D. Arnold, 2019, The Lancet Neurology.

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

Timothy A. Miller, Stephen A. Goutman, N. Staff, 2021, The Lancet Neurology.

Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma ≤2 cm

C. Sima, V. Rusch, M. Dunphy, 2013, Annals of Surgical Oncology.